They can produce IL-6 and promote the Th17/Treg subsets (10), a phenomenon well-described in allograft rejection (7), which may occur in HHT due to the defective endothelial quiescence resulting from disruption of the BMP9/10 pathway (29). The gene discussed is IL6; the disease is hereditary hemorrhagic telangiectasia.